Geriatric Medicine CME Courses

Geriatric Medicine CME Courses

Credits: 13 (AMA PRA Category 1)
Format: Interactive Online
Price: $399
Summary:

Developed by TMCI Global and the Society of Cannabis Clinicians (SCC), the Clinical Cannabinoid Medicine Curriclum is the first comprehensive, online CME-certified curriculum designed to educate the practicing clinician on both the research and clinical practice aspects of the therapeutic use of cannabis. Each course within the curriculum offers up to 1.5 AMA PRA Category 1 Credits™ and the complete curriculum is certified for up to 13 CME credits.

You Will Learn About

  • The fundamentals of the Endocannabinoid System
  • The use of cannabis in a clinical setting
  • The delivery and dosage of medical cannabis
  • Mental health and the psychiatric application of medical cannabis

* Includes a bonus module on Cannabinoid Chemistry authored by Dr. Raphael Mechoulam, a professor of Medicinal Chemistry at the Hebrew University of Jerusalem in israel and leading authority on Medical Cannabis science.

Target Audience: All healthcare practitioners; the curriculum was designed to educate the practicing clinician on both the research and clinical practice aspects of the therapeutic use of cannabis.

Purchase grants one learner one year’s access to lessons and quizzes (access expires 365 days from date of course activation).

Credits: 1.5 (AMA PRA Category 1)
Format: Online Streaming Video
Price: $25/hour
Release Date: 11/1/2015
Expiration Date: 10/31/2017
Summary: Course Objectives:
  • Ask questions that will help you understand the patient's Explanatory Model, or understanding, of her illness experience.
  • Base your approach to culture using the LEARN mnemonic: Listen, Explain, Acknowledge, Recommend, and Negotiate.
  • Ask and respond to patients' faith-based values and goals for care.
  • Help patients to anticipate and consider aspects of the dying process they might not have considered.
  • Open up communication with others who will be involved in patients' end-of-life care.
  • Incorporate patients' values and preferences in advance care planning.
  • How to respond to requests from a patient's family that raise ethical questions.
  • Determine how to offer truth in order to elicit your patients' preferences.
  • Negotiate solutions that respect patients' preferences as well as your ethical duty.
  • Look at the evidence for and against complementary and alternative medicine (CAM) practices.
  • Advise patientsbased on evidence.
  • Negotiate treatment plans with patients who incorporate CAM.
  • Build trust and have open communication with patients.
Credits: 1 (AMA PRA Category 1)
Format: Interactive Online
Price: Free
Release Date: 4/4/17
Expiration Date: 6/23/18
Summary:

Speakers

  • George T. Grossberg, MD Samuel W. Fordyce Professor; Director, Geriatric Psychiatry Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine
  • David Beck, MD Associate Professor, Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine

Topic and Learning Objectives

  • Identify different and various forms of agitation among patients with Alzheimer's disease (AD).
  • Review proposed mechanisms underlying agitation in AD and how pharmacologic agents may affect them
  • Evaluate body of evidence of current and emerging pharmacologic agents for the management of agitation/aggression in patients with AD

Share This